HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,283,072 | -3.5% | 344,311 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $11,693,074 | +30.6% | 332,284 | +21.2% | 0.00% | 0.0% |
| Q1 2023 | $8,954,785 | -40.9% | 274,266 | -0.2% | 0.00% | -33.3% |
| Q4 2022 | $15,144,455 | +27.1% | 274,854 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $11,915,000 | -4.0% | 269,017 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $12,413,000 | +9.4% | 254,530 | +9.2% | 0.00% | +50.0% |
| Q1 2022 | $11,342,000 | +10.4% | 233,134 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $10,269,000 | +26.2% | 240,824 | +13.4% | 0.00% | +100.0% |
| Q3 2021 | $8,138,000 | +51.6% | 212,308 | +11.7% | 0.00% | 0.0% |
| Q2 2021 | $5,367,000 | +136.1% | 190,121 | +176.4% | 0.00% | – |
| Q1 2021 | $2,273,000 | -15.2% | 68,786 | -7.3% | 0.00% | -100.0% |
| Q4 2020 | $2,682,000 | – | 74,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |